Riverside Partners Combines Sequoia Biotech Consulting and Syner-G BioPharma Group

Sequoia Consulting Group Acquires 42 North Solutions

February 22, 2023

Healthcare Services

Sequoia Consulting Group, a Riverside Partners portfolio company, has acquired 42 North Solutions, a Scituate, MA-based provider of capital project execution, facilities engineering, and facilities management services for pharmaceutical and biotechnology clients. The add-on expands Sequoia's East Coast presence, strengthens facilities management capabilities, and adds depth to its process, automation, and project engineering offerings; financial terms were not disclosed.

Syner-G BioPharma Group (Riverside Partners) Acquires RMC Pharmaceutical Solutions

January 24, 2023

Healthcare Services

Syner-G BioPharma Group, a portfolio company of Riverside Partners, has acquired RMC Pharmaceutical Solutions, an outsourced CMC and quality management services provider based in Colorado. The add-on strengthens Syner-G's pharmaceutical science capabilities—particularly biologics and cell & gene therapy development—by integrating RMC's process and analytical development, regulatory strategy, and quality management expertise.

Syner-G Acquires Impact Pharmaceutical Services

February 1, 2022

Healthcare Services

Syner-G BioPharma Group, a portfolio company of Riverside Partners, has acquired Impact Pharmaceutical Services, a Research Triangle Park-based provider of medical writing, regulatory strategy, and regulatory publishing services for biotech and pharmaceutical clients. The deal, which closed in late December, expands Syner-G's CMC and regulatory capabilities to better support clients across pre-IND through post-marketing stages; financial terms were not disclosed.

Riverside Partners Completes Platform Investment in Sequoia Consulting Group

January 18, 2022

Healthcare Services

Riverside Partners, a Boston-based private equity firm, completed a platform investment in Sequoia Consulting Group, a San Diego–headquartered life sciences consulting firm led by founder and CEO Brandy Bullen. The partnership will support Sequoia’s growth, capability expansion, and geographic reach as the company continues to provide technical operations, quality and scientific operations, business transformation, and program/project management services to biotech, pharma, diagnostics, and medical device clients.

Riverside Partners Merges Convergence Networks and Grade A

December 2, 2020

IT Services

Riverside Partners has completed the merger of Convergence Networks (Portland, Oregon) and Grade A (Ottawa, Canada) to form a combined managed IT and cybersecurity services platform serving small- and medium-sized businesses. Riverside invested new equity to accelerate growth, while management teams from both companies will continue to lead the combined organization and remain significant shareholders.

Riverside Partners Invests in Syner-G Pharma Consulting

October 29, 2020

Healthcare Services

Riverside Partners, a Boston-based private equity firm, completed an investment in Syner-G Pharma Consulting, a CMC regulatory and compliance consulting firm headquartered in Southborough, Massachusetts. The partnership with Syner-G's founders aims to support the company's next stage of growth, expand customer reach, and broaden service offerings to pharmaceutical and biotechnology clients.